Affordable Access

deepdyve-link
Publisher Website

COVID-19 and Pulmonary Mycobacterium Tuberculosis Coinfection

Authors
  • Al Lawati, Redha1
  • Al Busaidi, Nasser2
  • Al Umairi, Rashid3
  • Al Busaidy, Merah4
  • Al Naabi, Hanan Hamed4
  • Khamis, Faryal5
  • 1 Internal Medicine, COVID-19 Filed Hospital, Ministry of Health, Muscat, Oman
  • 2 Chest Medicine Unit, Royal Hospital, Muscat, Oman
  • 3 Department of Radiology, Royal Hospital, Muscat, Oman
  • 4 Acute Medicine Unit, Royal Hospital, Muscat, Oman
  • 5 Infectious Diseases Unit, Royal Hospital, Muscat, Oman
Type
Published Article
Journal
Oman Medical Journal
Publisher
Oman Medical Journal
Publication Date
Sep 28, 2021
Volume
36
Issue
5
Identifiers
DOI: 10.5001/omj.2022.23
PMCID: PMC8477439
Source
PubMed Central
Keywords
Disciplines
  • Case Reports
License
Unknown

Abstract

The Coronavirus disease-2019 (COVID-19) outbreak was classified as a global pandemic by the World Health Organization on 11 March 2020. It is caused by the novel severe acute respiratory syndrome coronavirus 2. The virus affects mainly the human respiratory system. Mycobacterium tuberculosis (TB) is another respiratory infection known to affect humans and may share joint clinical presentations and risk factors with COVID-19 infection. Therefore, clinicians must have a high index of suspicion that the two infections might coexist so that there is no delay in diagnosis and starting the appropriate treatment. There are few case reports about TB and COVID-19 coinfection. The first case report ever was from China and there have been a few others around the world. Here, we report two cases of coexisting COVID-19 and newly diagnosed pulmonary TB infection in Oman.

Report this publication

Statistics

Seen <100 times